Table 1.
Clinical characteristics, according to survival periods, of Adult T-cell Leukemia/Lymphoma (ATL) patients, diagnosed between 1st January 1983 and 31st March 2013 in Martinique.
| Mean age ± SDΔ (years) | Men (%) | ADP∗ (%) | HM† (%) | SM‡ (%) | CL§ (%) | Ca|| (%) | LDH# > 2N (%) | Ss∗∗ (%) | Eos∗∗∗≥ 1 × 109/L (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| All patients (N = 175) | 56.9 ± 17.0 | 50.3 | 80.0 | 21.7 | 18.3 | 43.4 | 46.9 | 55.4 | 42.5 | 16.0 |
|
| ||||||||||
| Patients not presenting with long survival (N = 165) | 57.5 ± 16.8 | 50.9 | 81.2 | 22.4 | 19.4 | 41.2 | 48.5 | 56.4 | 43.4 | 14.9 |
| Patients presenting with long survival (>10 years) (N = 10) | 44.0 ± 14.5 | 40.0 | 60.0 | 10.0 | 0.0 | 80.0 | 20.0 | 40.0 | 30.0 | 40.0 |
| P α | 0.017 | 0.760 | 0.104 | 0.356 | 0.125 | 0.016 | 0.077 | 0.313 | 0.559 | 0.038 |
∗ADP: adenomegaly, †HM: hepatomegaly, ‡SM: splenomegaly, §CL: cutaneous lesions, ||Ca: hypercalcemia, #LDH: lactate dehydrogenase, ∗∗Ss: Strongyloides stercoralis, ∗∗∗Eos: eosinophilia, and ΔSD: standard deviation; α P: level of significance set at 5%.